cached image

Nienke Elizabeth van Houten - Publications

2010- Health Sciences Simon Fraser University, Burnaby, British Columbia, Canada 
molecular immunology and vaccine design

6/6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Henry KA, Murira A, van Houten NE, Scott JK. Developing strategies to enhance and focus humoral immune responses using filamentous phage as a model antigen Bioengineered Bugs. 2: 275-283. PMID 22008640 DOI: 10.4161/Bbug.2.5.16559  0.32
2010 van Houten NE, Henry KA, Smith GP, Scott JK. Engineering filamentous phage carriers to improve focusing of antibody responses against peptides. Vaccine. 28: 2174-85. PMID 20056188 DOI: 10.1016/J.Vaccine.2009.12.059  0.76
2010 Irving MB, Craig L, Menendez A, Gangadhar BP, Montero M, van Houten NE, Scott JK. Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes. Molecular Immunology. 47: 1137-48. PMID 20031219 DOI: 10.1016/J.Molimm.2009.10.015  0.76
2008 Montero M, van Houten NE, Wang X, Scott JK. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiology and Molecular Biology Reviews : Mmbr. 72: 54-84, table of cont. PMID 18322034 DOI: 10.1128/Mmbr.00020-07  0.76
2007 Saphire EO, Montero M, Menendez A, van Houten NE, Irving MB, Pantophlet R, Zwick MB, Parren PW, Burton DR, Scott JK, Wilson IA. Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies. Journal of Molecular Biology. 369: 696-709. PMID 17445828 DOI: 10.1016/J.Jmb.2007.01.060  0.32
2006 van Houten NE, Zwick MB, Menendez A, Scott JK. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide. Vaccine. 24: 4188-200. PMID 16488517 DOI: 10.1016/J.Vaccine.2006.01.001  0.32
Hide low-probability matches.